Rigel Pharma (RIGL) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $47.09 --0%
Revenue Growth %: +15.2%
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +15.2%
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q3 EPS of ($0.14), $0.01 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $4.9 million versus the consensus estimate of $3.93 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Darling Ingredients (DAR) PT Raised to $88 at UBS
- William Blair Downgrades Endava PLC (ADR) (DAVA) to Underperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
